[HTML][HTML] Increased Thrombotic Risk in COVID-19: Evidence and Controversy
The pandemic of respiratory disease caused by the novel coronavirus named SARS-CoV-2,
which emerged at the end of 2019, is still ongoing [1, 2]. Many scientific reports worldwide …
which emerged at the end of 2019, is still ongoing [1, 2]. Many scientific reports worldwide …
[HTML][HTML] Increased Thrombotic Risk in COVID-19: Evidence and Controversy
A De Vita, F Franceschi, M Covino - Journal of Clinical Medicine, 2023 - ncbi.nlm.nih.gov
The pandemic of respiratory disease caused by the novel coronavirus named SARS-CoV-2,
which emerged at the end of 2019, is still ongoing [1, 2]. Many scientific reports worldwide …
which emerged at the end of 2019, is still ongoing [1, 2]. Many scientific reports worldwide …
[引用][C] Increased Thrombotic Risk in COVID-19: Evidence and Controversy.
A De Vita, F Franceschi, M Covino - Journal of Clinical Medicine, 2023 - europepmc.org
Increased Thrombotic Risk in COVID-19: Evidence and Controversy. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
[引用][C] Increased Thrombotic Risk in COVID-19: Evidence and Controversy
A De Vita, F Franceschi… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
The pandemic of respiratory disease caused by the novel coronavirus named SARS-CoV-2,
which emerged at the end of 2019, is still ongoing [...].
which emerged at the end of 2019, is still ongoing [...].
Increased Thrombotic Risk in COVID-19: Evidence and Controversy
A De Vita, F Franceschi… - Journal of Clinical …, 2023 - search.proquest.com
of personal and institutional precautions, along with the ongoing vaccination campaign,
there has been a decrease in the number of patients with severe respiratory disease caused …
there has been a decrease in the number of patients with severe respiratory disease caused …